Pulmatrix continues to support Cullgen in seeking approval for their merger from the China Securities Regulatory Commission FRAMINGHAM, Mass., Dec. 18, 2025 /PRNewswire/ -- Pulmatrix, Inc. ("Pulmatrix" or the "Company") (Nasdaq: PULM), a biopharmaceutical company that has focused on the...
Hence then, the article about pulmatrix and cullgen continue to pursue merger while granting each other waivers to explore alternatives was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Pulmatrix and Cullgen Continue to Pursue Merger While Granting Each Other Waivers to Explore Alternatives )
Also on site :
- Skanska signs additional contract with existing client to build a data center in USA for USD 228M, about SEK 2.2 billion
- ‘No way out’: Telangana student dies in Germany after jumping from burning apartment on New Year’s Eve
- Switzerland fire latest: King Charles ‘heartbroken’ after 40 killed in ‘horrific’ Crans Montana bar disaster